TWA
TMO icon

TCI Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

TCI Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Buy
462
+31
+7% +$14.9K 0.01% 242
2026
Q1 		$212K Buy
431
+22
+5% +$11.9K 0.01% 235
2025
Q4 		$237K Sell
409
-11
-3% -$6.22K 0.01% 215
2025
Q3 		$204K Buy
+420
New +$195K 0.01% 255
2025
Q2 		– Sell
-603
Closed -$300K – 264
2025
Q1 		$300K Sell
603
-304
-34% -$165K 0.02% 170
2024
Q4 		$472K Sell
907
-70
-7% -$38.5K 0.04% 129
2024
Q3 		$604K Sell
977
-21
-2% -$12.4K 0.05% 113
2024
Q2 		$552K Buy
998
+10
+1% +$5.73K 0.05% 115
2024
Q1 		$574K Hold
988
– – 0.06% 112
2023
Q4 		$524K Sell
988
-107
-10% -$51.8K 0.06% 113
2023
Q3 		$554K Sell
1,095
-36
-3% -$19.2K 0.07% 100
2023
Q2 		$590K Hold
1,131
– – 0.08% 100
2023
Q1 		$652K Buy
1,131
+37
+3% +$20.9K 0.08% 90
2022
Q4 		$602K Sell
1,094
-170
-13% -$90.1K 0.08% 88
2022
Q3 		$641K Buy
1,264
+27
+2% +$15.1K 0.1% 81
2022
Q2 		$672K Buy
1,237
+419
+51% +$231K 0.1% 81
2022
Q1 		$483K Sell
818
-34
-4% -$19.5K 0.07% 103
2021
Q4 		$568K Sell
852
-15
-2% -$9.37K 0.08% 96
2021
Q3 		$495K Buy
867
+65
+8% +$35.7K 0.08% 113
2021
Q2 		$405K Buy
802
+120
+18% +$56.6K 0.07% 130
2021
Q1 		$311K Buy
682
+23
+3% +$11K 0.13% 132
2020
Q4 		$307K Hold
659
– – 0.14% 127
2020
Q3 		$291K Sell
659
-20
-3% -$8.26K 0.12% 127
2020
Q2 		$246K Sell
679
-57
-8% -$19.1K 0.11% 130
2020
Q1 		$209K Sell
736
-27
-4% -$8.51K 0.1% 140
2019
Q4 		$248K Buy
763
+123
+19% +$37.3K 0.1% 147
2019
Q3 		$186K Buy
640
+105
+20% +$30.1K 0.08% 152
2019
Q2 		$157K Sell
535
-25
-4% -$6.89K 0.07% 166
2019
Q1 		$153K Sell
560
-10
-2% -$2.49K 0.07% 182
2018
Q4 		$128K Buy
570
+4
+0.7% +$938 0.06% 183
2018
Q3 		$138K Hold
566
– – 0.06% 192
2018
Q2 		$117K Buy
566
+31
+6% +$6.58K 0.05% 201
2018
Q1 		$110K Sell
535
-70
-12% -$14.7K 0.05% 207
2017
Q4 		$115K Buy
605
+100
+20% +$19.2K 0.05% 212
2017
Q3 		$96K Sell
505
-4
-0.8% -$724 0.05% 217
2017
Q2 		$89K Buy
509
+14
+3% +$2.35K 0.05% 215
2017
Q1 		$76K Sell
495
-3
-0.6% -$459 0.04% 247
2016
Q4 		$70K Hold
498
– – 0.04% 277
2016
Q3 		$79K Sell
498
-4
-0.8% -$616 0.04% 242
2016
Q2 		$74K Hold
502
– – 0.04% 249
2016
Q1 		$71K Sell
502
-8
-2% -$1.07K 0.04% 248
2015
Q4 		$72K Buy
510
+365
+252% +$48.7K 0.04% 248
2015
Q3 		$18K Hold
145
– – 0.01% 417
2015
Q2 		$19K Sell
145
-20
-12% -$2.61K 0.01% 418
2015
Q1 		$22K Buy
165
+20
+14% +$2.58K 0.01% 344
2014
Q4 		$18K Hold
145
– – 0.01% 367
2014
Q3 		$18K Hold
145
– – 0.01% 350
2014
Q2 		$17K Hold
145
– – 0.01% 372
2014
Q1 		$17K Hold
145
– – 0.01% 343
2013
Q4 		$16K Hold
145
– – 0.01% 361
2013
Q3 		$13K Sell
145
-1,135
-89% -$103K 0.01% 340
2013
Q2 		$108K Buy
+1,280
New +$107K 0.08% 149

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

TCI Wealth Advisors's TMO Position: Q2 2026 in Review

TCI Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.2% in Q2 2026, buying an estimated $14.9K and bringing the position to 462 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #242.

TCI Wealth Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $672K in Q2 2022. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • TCI Wealth Advisors held 462 shares of Thermo Fisher Scientific worth $232K as of Q2 2026.
  • TCI Wealth Advisors bought 31 Thermo Fisher Scientific shares in Q2 2026, an estimated $14.9K.
  • Thermo Fisher Scientific made up 0.01% of TCI Wealth Advisors's portfolio in Q2 2026, its #242 holding.
  • TCI Wealth Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • TCI Wealth Advisors's Thermo Fisher Scientific position peaked at $672K in Q2 2022.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on TCI Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.